Europe Pulmonary Devices Market Outlook and Strategic Insights by 2027

The Europe pulmonary devices market is expected to reach US$ 11,398.02 million by 2027 from US$ 5,459.48 million in 2019; it is estimated to grow at a CAGR of 9.7% from 2020 to 2027.

Pulmonary or respiratory devices are used to remove mucus and secretions from the airways or the respiratory tract. These medical devices are focused on diagnosis, control, treatment, management, and evaluation of the problems associated with respiratory tract.

Infectious respiratory diseases directly impel the demand for respiratory care. The demand for ventilators has also developed due to the COVID-19 outbreak, resulting in governmental and industrial support for driving the pace of manufacturing. For instance, in Italy, hospitals have reported to witness an exponential rise in the number of patients with respiratory ailments, and the medical staff is struggling to provide necessary aids to reduce the number of COVID-19 related deaths. As the shortage and prevalence of respiratory diseases increase, the pulmonary device market is expected to witness significant growth.

Further, international regulatory agencies are considering accelerated approval of specific respiratory devices. For instance, in the UK, the government has asked automobile manufacturers, including Ford, Honda, and Rolls-Royce, to temporarily shift part of their assembly line focus from cars to developing respiratory equipment. Once an agreement is reached, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) must ensure that the automakers adhere to the set rules and regulations. Thus, the rapid spread of COVID-19 leading to pulmonary failure has led to a growing demand for ventilators and respiratory devices, thereby driving the market growth.

The COVID-19 pandemic effect is still very active among various countries in the Europe. As with any specialized equipment simply commandeering a factory and ordering it to manufacture respirators is not a reality, the existing equipment are retooled and quality control perfected under these circumstances to operate as alternative solutions for invasive ventilators. Various companies are working towards providing these solutions to the healthcare centers in the Europe and are thus likely to create a good business even during the pandemic.

Rest of the Europe Pulmonary Devices Market, Revenue and Forecast to 2027 (US$ Mn)

EUROPE PULMONARY DEVICES MARKET SEGMENTATION

By Type

• Therapeutic Devices
• Consumables and Accessories
• Diagnostic Devices
• Monitoring Devices

By Application

• Chronic Obstructive Pulmonary Disease (COPD)
• Sleep Apnea
• Asthma
• Infectious Diseases
• Others

By End User

• Hospitals
• Home Care Settings
• Ambulatory Care Centers

By Country

• Germany
• France
• United Kingdom
• Italy
• Spain

Company Profiles

• Medtronic
• Dragerwerk AG & Co. KGaA
• Air Liquide
• Hamilton Medical
• Koninklijke Philips N.V.
• Getinge AB

Europe Pulmonary Devices Report Scope